Gadopenamide
- Level
- Commodity
- Parent
- 51172300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51172335This classification denotes a gadolinium-chelate with the molecular formula C22H34N5O10.Gd, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VC7M3XD17L, chemically known as (n,n-bis(2-((carboxymethyl)((morpholinocarbonyl)methyl)amino)ethyl)glycinato(3-))gadolinium but more generally known as gadopenamide, which bears US NIH Compound Identifier 3034033. European Medicines Agency schedules Gadopenamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07863MIG. The term GADOPENAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). GADOPENAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: [GD].O1CCN(CC1)C(=O)CN(CCN(CCN(CC(=O)N1CCOCC1)CC(=O)O)CC(=O)O)CC(=O)O.
Same parent
Under 51172300 · 40Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.